Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a12-3283_18k.htm

Exhibit 99

 

 

SILICON LABORATORIES RESULTS EXCEED EXPECTATIONS

 

Strong Quarterly Performance and Better than Seasonal Outlook—

 

AUSTIN, Texas — Jan. 25, 2012 — Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported fourth quarter revenue of $126.7 million, a 13 percent increase compared to the same period last year.  GAAP and non-GAAP earnings per share of $0.29 and $0.49, respectively, exceeded expectations and represented solid double-digit sequential growth.

 

Financial Highlights

 

Business trends were robust throughout the quarter, with new product cycles driving revenue upside.  Solid operating performance also translated to better than anticipated profitability.

 

Fourth quarter revenue increased more than 6 percent sequentially to $126.7 million. GAAP gross margin was 60.9 percent.  R&D investment increased to $34.7 million, and SG&A was flat at $27.3 million.  Operating income improved meaningfully from the same period last year to 12 percent. GAAP net income was 10 percent of revenue for the quarter. Diluted GAAP earnings of 29 cents represented a 12 percent increase compared to the third quarter.

 

The following non-GAAP results exclude the impact of stock compensation expense and certain other one-time items. Gross margin remained stable at 61.2 percent.  R&D investment increased to $29.6 million due primarily to increased tape out activity, and as planned, SG&A remained flat at $22.5 million. Operating income improved to 20 percent of revenue, and net income improved to 17 percent of revenue. The solid operational performance resulted in diluted earnings per share of 49 cents, an 11 percent sequential increase, and well above guidance.  The company ended the quarter with $325 million in cash, cash equivalents and investments due to continued healthy cash flow from operations.

 



 

Reconciling charges are set forth in the financial measures table included below.

 

Business Highlights

 

Fourth quarter revenue upside was driven by new product cycles in video and touch controllers, as well as better than anticipated demand for SLIC devices and many of the company’s Broad-based products.

 

The company’s video products exceeded the full year revenue target and exited the year positioned to further expand its strong market share position as customers ramp 2012 TV models into production. iDTVs featuring the company’s latest generation products were on display at the Consumer Electronics Show, demonstrating the form factor and performance advantages available when using Silicon Labs silicon tuner technology.

 

Similarly, the company’s touch controllers designed into mobile handsets exceeded initial forecasts, shipping throughout Europe, China and India during the fourth quarter. This rapid ramp in a major mobile handset platform was strong validation for the company’s touch technology and a good foundation for expanding market share in 2012.

 

The company’s non-consumer products also delivered solid performance in the quarter, including MCUs, which remained stable, and isolation and wireless products which grew significantly as new customer programs ramped.  Timing products delivered excellent year over year growth again at 30 percent, but slowed in the fourth quarter in conjunction with the near-term weakness in the telecom equipment market.

 

“We enjoyed a sustained improvement in the strength of bookings as we ended 2011. And with our recent results demonstrating significant share gains, we have a lot to look forward to in 2012,” said Necip Sayiner, president and CEO of Silicon Laboratories. “We believe we have both the diversity to weather any lingering macro weakness and the product cycles to get us back into a mode of consistently outperforming our peers.”

 

The company expects revenue for the first quarter to be in the range of $120 million to $125 million.

 



 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. central time. An audio webcast will be available simultaneously on Silicon Laboratories’ website under Investor Relations (www.silabs.com).  A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or +1 (404) 537-3406 (international) and by entering 42298945. The replay will be available through February 8th.

 

About Silicon Laboratories Inc.

 

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories’ diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Laboratories’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; inventory-related risks; risks associated with acquisitions; difficulties managing international activities; difficulties managing our manufacturers and subcontractors; risks that Silicon Laboratories may not be able to manage strains associated with

 



 

its growth; credit risks associated with our accounts receivable; dependence on key personnel; risks associated with divestitures; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories’ filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Year Ended

 

 

 

December 31,

 

January 1,

 

December 31,

 

January 1,

 

 

 

2011

 

2011

 

2011

 

2011

 

Revenues

 

$

126,692

 

$

111,891

 

$

491,625

 

$

493,341

 

Cost of revenues

 

49,513

 

40,800

 

193,179

 

169,097

 

Gross margin

 

77,179

 

71,091

 

298,446

 

324,244

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

34,705

 

32,621

 

135,953

 

123,821

 

Selling, general and administrative

 

27,251

 

27,456

 

112,419

 

113,752

 

Operating expenses

 

61,956

 

60,077

 

248,372

 

237,573

 

Operating income

 

15,223

 

11,014

 

50,074

 

86,671

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

427

 

479

 

1,859

 

2,318

 

Interest expense

 

(23

)

(11

)

(37

)

(77

)

Other income (expense), net

 

152

 

24

 

444

 

(1,253

)

Income before income taxes

 

15,779

 

11,506

 

52,340

 

87,659

 

Provision (benefit) for income taxes

 

2,974

 

(1,377

)

16,868

 

14,417

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

12,805

 

$

12,883

 

$

35,472

 

$

73,242

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.31

 

$

0.29

 

$

0.82

 

$

1.63

 

Diluted

 

$

0.29

 

$

0.28

 

$

0.79

 

$

1.57

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

41,979

 

43,834

 

43,421

 

44,845

 

Diluted

 

43,410

 

45,658

 

44,832

 

46,742

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
December 31, 2011

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Acquisition
Related
Items

 

Termination
Costs and
Impairments

 

Non-
GAAP
Measure

 

Non-
GAAP
Percent of
Revenue

 

Revenues

 

$

126,692

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

77,179

 

60.9

%

$

304

 

$

 

$

 

$

77,483

 

61.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

34,705

 

27.4

%

3,588

 

 

1,553

 

29,564

 

23.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

27,251

 

21.5

%

5,000

 

(560

)

345

 

22,466

 

17.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

15,223

 

12.0

%

8,892

 

(560

)

1,898

 

25,453

 

20.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

12,805

 

10.1

%

7,629

 

(560

)

1,510

 

21,384

 

16.9

%

 

 

 

Three Months Ended
December 31, 2011

 

 

 

Non-GAAP Diluted
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense

 

Acquisition
Related
Items

 

Termination
Costs and
Impairments

 

Non-
GAAP
Measure

 

 

 

Net income

 

$

12,805

 

$

7,629

 

$

(560

)

$

1,510

 

$

21,384

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

43,410

 

 

 

 

 

 

 

43,410

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.29

 

 

 

 

 

 

 

$

0.49

 

 

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

December 31,
2011

 

January 1,
2011

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

94,964

 

$

138,567

 

Short-term investments

 

212,526

 

227,295

 

Accounts receivable, net of allowance for doubtful accounts of $725 at December 31, 2011 and $772 at January 1, 2011

 

55,351

 

45,030

 

Inventories

 

34,778

 

39,450

 

Deferred income taxes

 

11,563

 

9,140

 

Prepaid expenses and other current assets

 

43,867

 

34,447

 

Total current assets

 

453,049

 

493,929

 

Long-term investments

 

17,477

 

17,500

 

Property and equipment, net

 

25,141

 

29,945

 

Goodwill

 

115,489

 

112,296

 

Other intangible assets, net

 

60,005

 

53,242

 

Other assets, net

 

34,830

 

20,746

 

Total assets

 

$

705,991

 

$

727,658

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

26,354

 

$

24,433

 

Accrued expenses

 

30,857

 

25,604

 

Deferred income on shipments to distributors

 

24,962

 

26,127

 

Income taxes

 

665

 

3,692

 

Total current liabilities

 

82,838

 

79,856

 

Long-term obligations and other liabilities

 

24,214

 

22,372

 

Total liabilities

 

107,052

 

102,228

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock—$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$0.0001 par value; 250,000 shares authorized; 42,068 and 43,933 shares issued and outstanding at December 31, 2011 and January 1, 2011, respectively

 

4

 

4

 

Additional paid-in capital

 

14,749

 

49,947

 

Retained earnings

 

586,653

 

579,127

 

Accumulated other comprehensive loss

 

(2,467

)

(3,648

)

Total stockholders’ equity

 

598,939

 

625,430

 

Total liabilities and stockholders’ equity

 

$

705,991

 

$

727,658

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Year Ended

 

 

 

December 31,
2011

 

January 1,
2011

 

Operating Activities

 

 

 

 

 

Net income

 

$

35,472

 

$

73,242

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

13,570

 

11,797

 

Amortization of other intangible assets and other assets

 

11,030

 

7,494

 

Impairment of long-lived assets

 

1,322

 

 

Stock-based compensation expense

 

36,115

 

40,324

 

Income tax benefit from employee stock-based awards

 

2,814

 

3,295

 

Excess income tax benefit from employee stock-based awards

 

(2,404

)

(2,412

)

Deferred income taxes

 

(445

)

(552

)

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(8,562

)

11,342

 

Inventories

 

5,334

 

(7,811

)

Prepaid expenses and other assets

 

(5,948

)

(5,300

)

Accounts payable

 

(2,176

)

(777

)

Accrued expenses

 

(1,320

)

(2,590

)

Deferred income on shipments to distributors

 

(1,915

)

(2,343

)

Income taxes

 

5,855

 

(7,774

)

Net cash provided by operating activities

 

88,742

 

117,935

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(178,676

)

(357,777

)

Proceeds from sales and maturities of marketable securities

 

193,474

 

352,779

 

Purchases of property and equipment

 

(8,690

)

(13,850

)

Purchases of other assets

 

(4,018

)

(8,372

)

Acquisitions of businesses, net of cash acquired

 

(27,262

)

(28,021

)

Net cash used in investing activities

 

(25,172

)

(55,241

)

Financing Activities

 

 

 

 

 

Proceeds from issuance of common stock, net of shares withheld for taxes

 

7,660

 

18,055

 

Excess income tax benefit from employee stock-based awards

 

2,404

 

2,412

 

Repurchases of common stock

 

(110,063

)

(140,331

)

Payments on debt

 

(7,174

)

 

Net cash used in financing activities

 

(107,173

)

(119,864

)

 

 

 

 

 

 

Decrease in cash and cash equivalents

 

(43,603

)

(57,170

)

Cash and cash equivalents at beginning of period

 

138,567

 

195,737

 

Cash and cash equivalents at end of period

 

$

94,964

 

$

138,567

 

 

 #  #  #